Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
Ying Liang, M.D., Ph.D., obtained her first NIH R01 grant to fund her research on the role of a protein called latexin in preventing cancer therapy-induced stem cell damage.
Hear rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope.
CTSA Program support enables clearest-ever image of key enzyme in cancer, aging.
NCATS SMART IRB Reliance Platform to serve as roadmap for new NIH policy.
Learn about NCATS’ new rare diseases patient video series, a possible treatment for Parkinson’s and Gaucher, a CTSA Program training success, and more.
BEST Resource Glossary
This online glossary clarifies terms used in translational science and medical product development.
Assay Guidance Manual
Use this NCATS-supported tool to develop tests for high-throughput screening projects.
Christopher P. Austin, M.D.
Petra Kaufmann, M.D., M.Sc., director of the NCATS Office of Rare Diseases Research and Division of Clinical Innovation, discusses how CTSA Program support is speeding the translation of research discoveries into health benefits. View the video.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …